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Editorial 
BACK TO THE NORMALCY;  
IS IT POSSIBLE AFTER THE LATEST 
CORONAVIRUS DISEASE-COVID-19 ATTACK?     
While writing these sentences I feel a sharp pain in my throat and even 
sharper is disturbing my heart- the fear of severe contagious disease. At 
the same time stressful radio news warn me how the infection could be 
dangerous: informing about the number of newly diagnosed, those 
who died yesterday, and those that are on ventilators. 
On December 29, 2019 the first four cases of “pneumonia of 
unknown etiology” were identified by local hospitals, all linked to the 
Huanan (Southern China) Seafood Whole-Sale Market. Since then an 
increasing number of cases of novel coronavirus pneumonia have been 
identified in Wuhan, a large city of 11 million people in Central China 
[1]. Pneumonia of unknown etiology is defined as an illness without 
identified causative pathogen that fulfills following criteria: fever 
(≥38°C), radiographic evidence of pneumonia, low or normal white 
blood cell count or low lymphocyte count, and no symptomatic 
improvement after antimicrobial treatment for 3 to 5 days following 
the standard clinical guidelines. Severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus 
disease 2019 (COVID-19), was quickly identified. On January 31, 
2020, the WHO declared coronavirus a global health emergency. It 
abruptly generated a worldwide pandemic [1, 2]. The experience from 
Severe Acute Respiratory Syndrome (SARS) and the Middle East 
respiratory syndrome (MERS) case definitions as recommended by the 
WHO in 2003 and 2012 respectively were applied, but the new 
coronavirus unexpectedly showed its sneaky nature. It was different 
and it produced confusion and uncertainty among members of “The 
expert community”. Whoever gave opinions and prognoses was deeply 
wrong.  
Coronavirus outbreak forced us to interrupt our normal activi-
ties and to postpone our annual meetings and congresses. It seemed 
that it disrupted all activities on the planet except the bare essen-
tials. The burden of the severe cases of SARS-CoV-2 overwhelmed 
health care capacities even in the developed western countries. Be-
sides infectologists, pulmonologists, and anesthesiologists, many 
different specialists and subspecialists were engaged as first - line 
practitioners in the triage of suspected patients and even in the 
treatment of severely ill patients in need of vital support. The 
younger ones have been forced to work for months in so-called 
COVID - hospitals, changing their focus of clinical practice and 
scientific interest towards practical essentials in the treatment of 
COVID-19 infected patients. Virus gave us a lecture on how arro-
gant but helpless and minor we are at the same time. We are not 
permitted to go outside without masks, to shake hands with col-
leagues, nor to hug friends or family members-restrictions advised 
to patients with immunodeficiency. Just as COVID-19 causes 
physiological dysfunction in patients, so too, it caused systemic 
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dysfunction in households, institutions, cities, and nations [2, 3]. In 
every evil, some benefit could lie: air pollution decreased, rivers 
became cleaner, terrorism stopped and wars halted. The flora and 
fauna are relieved. 
Coronaviruses have been well known for decades as commonest 
pathogens, besides rhinoviruses and Respiratory Syncytial Virus 
(RSV) responsible for the upper respiratory tract infections in chil-
dren and adults- the common cold (coryza) when patients and par-
ents were advised that there is no need for specific curative treat-
ment. The illness was mild and self-limiting. What changed this 
coronavirus from harmless to virus responsible for the high mortal-
ity rate among affected individuals? The virus obviously transformed 
its nature, but that is us who also changed. Our immune system is 
overreacting or stay in ignorant condition once the virus entered the 
body. Some individuals, mainly young people and children, in good 
condition as sportists, did not show any sign of disease, while others 
were producing strong infammation and even „cytokine storm“.  
Virus taught us what are fundamental human needs, besides 
essentials for life: food, water, shelter, sleep, physical and emotional 
connections and need for novelties. Novelty creates the opportunity 
to learn and the potential to fail. Without novelties, motivation wanes 
and a healthy sense of well-being is lost. Furthermore people need a 
place to gain and share knowledge, empowering to learn from others 
and better understand the world. Contentedness increases self-
esteem, a sense of security, a sense of belonging... The virus 
jeopardized all above mentioned human needs. 
What are the facts and controversies about the current pandemic? 
In order to invade host cells SARS-CoV-2 (the virus responsible 
for the COVID-19 pandemic) and SARS-CoV-1 (responsible for the 
SARS epidemic in 2002) need to bind cell surface receptor 
angiotenzin-converting enzyme 2 (ACE2). They are expressed mainly 
in lungs, heart and kidneys. These receptors are sparse in children, 
explaining why children are less affected. This entry into host cells 
requires besides ACE2, the cleavage of S-spike protein of the corona 
virus surface by transmembrane protease serine 2 (TMPRSS2), which 
thus represents a critical host cell factor for the invasion and spread 
of the virus. The protease is upregulated by androgens, the fact that 
clarifies why male subjects are more frequently affected. Thus, it is 
also expected that hypertensive patients treated with the ACE 
inhibitors could have facilitated viral invasion [4, 5]. 
Captopril has recently been questioned for patients with diabetes 
in COVID-19 settings. Although ACE inhibitors and angiotensin 
receptor blockers (ARBs) are generally considered to have similar 
adverse event profiles, evaluation of postmarketing adverse events 
may shed light on minute differences that could have important 
clinical impacts during actual pandemic. Captopril appears to be 
associated with a higher rate of pulmonary adverse reactions in 
patients with diabetes than other ACE inhibitors or ARBs and 
therefore may not be the best choice for patients with diabetes and 
COVID-19, a new study suggests [5]. 
What was not curiosity for me as an endocrinologist is the new 
study's result that dexamethasone reduced mortality by one-third in 
ventilated patients and by one fifth in other patients receiving oxygen 
only.The study stoped because the survival benefit for a life-
threatening disease was obvious. Continuing the study as originally 
designed is unethical — those randomized to receive “usual care” 
would be deprived of a potentially life-saving treatment [6,7]. Aside 
from those patients in whom corticosteroids are contraindicated, it is 
hard to imagine to not offer dexhametasone nowadays to a person 
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with COVID-19 who requires supplemental oxygen or ventilator 
support [6]. It is well known that adequate adrenocortical function is 
essential for survival in critical illness. Most critically ill patients 
display elevated plasma cortisol concentrations, which reflect 
activation of the hypothalamic-pituitary-adrenal axis and is 
considered to be a homeostatic adaptation. However, many critically 
ill patients have “relative” or “functional” adrenal insufficiency, 
which is characterized by an inadequate production of cortisol in 
relation to an increased demand during periods of severe stress. Not 
so recently, the term “critical illness-related corticosteroid 
insufficiency” (CIRCI) was introduced. CIRCI occurs as a result of a 
decrease in adrenal steroid production or tissue resistance to 
glucocorticoids [8]. Thus, It is reasonable to apply dexamethasone or 
methyprednisolone in severe COVID-19 or any other severe 
pneumonia as our pulmonologists have actually been doing for years. 
There is another intriguing involvement of endocrine system with 
potential to produce long term consequences on growth and 
development in children, as well as on the well-being, healthy aging or 
even survival in adults.It is the potential of affecting the pituitary gland. 
Namely, hypocortisolism in survivors of SARS was reported in 2005. 
The authors speculated that the coronavirus infection could have 
caused a reversible hypophysitis [4,9]. Reversible or permanent - the 
time will show. So we must be prepared for a potential long-term 
endocrine impact of the disease that will reveal its real nature in the 
future. 
Is a coagulation cascade crucial for the development of clinical 
presentation from the very beginning or its activation means final 
event? We consulted prof. Jovan Antović, PhD, an expert and 
Research Group Leader from Clinical Chemistry - Coagulation, 
Dept. Molecular Medicine Surgery and Medical head Coagulation 
Clinical Chemistry, Karolinska University Laboratory, and a member 
of our Editorial board to clarify the coagulation cascade activation in 
SARS-CoV-2. He opened many questions and offered solutions of 
critical importance for avoiding the fatal outcome. To find more on 
this topic read the Opinion Article that professor Antovic kindly 
accepted to write for Facta. He presented the first experiences in 
investigation and treatment of such patients in his institution [10]. 
 Under pandemic circumstances and curfew, telemedicine finds its 
place in follow-up and surveillance of the older population with 
chronic diseases. Our Italian colleague Susanne Buechner and her team 
from the Department of Neurology/Stroke Unit, Bolzano Hospital, 
Bolzano/Bozen Italy shared their experience in applying telemedicine 
as an effective tool that replaces periodic medical examinations in 
patients suffering from Parkinson’s disease during COVID-19 
pandemic when non urgent medical visits were impossible [11]. 
In the middle of this crisis we should behave like professionals 
and focus our energy on contribution to widen knowledge and 
share experiences; how to boost our immune system to resist the 
fatal infection or how to halt a “storm we have never seen before”, 
a cytokine storm adjacent by deleterious disseminated intravascular 
coagulation.Endocrine system as critical for survival should take a 
big part in investigation of hormonal differences between survivors 
and non-survivors during this pandemic.  
I find appropriate to finish this Editorial by citing Juval Noa 
Harari, who said: “Forced physical distance and separation will 
create a new closeness and intimacy between people. The importance 
of the health system and health workers will be re-appreciated.The 
greatest danger is not the virus itself but our own inner demons, our 
hatred, greed and ignorance”. 
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